RXO (NYSE:RXO) Given New $22.00 Price Target at Barclays

RXO (NYSE:RXO) had its target price reduced by Barclays from $24.00 to $22.00 in a research report report published on Wednesday,Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other equities research analysts also recently weighed in on RXO. Truist Financial began coverage on shares of RXO in a research note on Thursday, March 13th. They set a “buy” rating and a $24.00 target price on the stock. Stifel Nicolaus cut their price objective on RXO from $27.00 to $24.00 and set a “hold” rating on the stock in a research report on Thursday, February 6th. Wells Fargo & Company reduced their price objective on RXO from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 27th. Morgan Stanley lowered their target price on RXO from $27.00 to $25.00 and set an “equal weight” rating for the company in a research note on Thursday, February 6th. Finally, Jefferies Financial Group reduced their price target on RXO from $33.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, RXO presently has a consensus rating of “Hold” and a consensus target price of $24.80.

RXO Trading Up 3.3 %

RXO opened at $19.54 on Wednesday. RXO has a 52 week low of $17.50 and a 52 week high of $32.82. The company has a quick ratio of 1.33, a current ratio of 1.26 and a debt-to-equity ratio of 0.22. The business has a fifty day simple moving average of $20.93 and a 200-day simple moving average of $25.05. The firm has a market cap of $3.19 billion, a P/E ratio of -9.22, a P/E/G ratio of 4.55 and a beta of 1.67.

RXO (NYSE:RXO) last announced its earnings results on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, meeting analysts’ consensus estimates of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. On average, equities analysts expect that RXO will post 0.31 earnings per share for the current year.

Institutional Trading of RXO

A number of hedge funds and other institutional investors have recently made changes to their positions in RXO. Wellington Management Group LLP grew its stake in RXO by 24.8% during the 4th quarter. Wellington Management Group LLP now owns 1,952,884 shares of the company’s stock worth $46,557,000 after buying an additional 387,766 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of RXO by 48.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 18,115 shares of the company’s stock valued at $432,000 after acquiring an additional 5,874 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of RXO during the fourth quarter worth approximately $3,738,000. Mackenzie Financial Corp increased its holdings in shares of RXO by 37.2% in the 4th quarter. Mackenzie Financial Corp now owns 9,967 shares of the company’s stock valued at $238,000 after acquiring an additional 2,700 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in RXO by 15.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 285,504 shares of the company’s stock valued at $6,806,000 after purchasing an additional 37,916 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.